Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of Healthcare Engineering"
DOI: 10.1155/2022/2842066
Abstract: Purpose This study aims to determine the influence of targeting araC-resistant acute myeloid leukemia by dual inhibition cyclin-dependent protein kinase (CDK9) and B-cell lymphoma-2 (Bcl-2). Method The c-Myc inhibitor 10058-F4 and the CDK9 inhibitor AZD4573…
read more here.
Keywords:
myeloid leukemia;
resistant acute;
cdk9;
targeting arac ... See more keywords